S100A13 and central nervous system cancer: The tight interaction between both proteins was supported by the in situ PLA assay, in which intense amplified signals were observed 1.5 and 3 h after the serum deprivation of C6 glioma cells in the presence of amlexanox, which prevents the extracellular release of S100A13.